Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

May 10, 2017 — Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to ...

Home May 10, 2017
Home
News | EP Mapping and Imaging Systems

May 2, 2017 — Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole ...

Home May 02, 2017
Home
News | Left Atrial Appendage (LAA) Occluders

April 25, 2017 — AtriCure Inc. announced it has sold more than 100,000 AtriClip Left Atrial Appendage Exclusion System ...

Home April 25, 2017
Home
An electrophysiology EP ablation procedure to treat a heart arrhythmia
Feature | HRS

May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017 ...

Home May 16, 2017
Home
News | Atrial Fibrillation

April 10, 2017 — Medtronic recently announced the first enrollments in the STOP Persistent AF clinical trial. The study ...

Home April 11, 2017
Home
atricure atriclip, LAA occlusion, acc17
Feature | Left Atrial Appendage (LAA) Occluders

March 29, 2017 — For patients with atrial fibrillation (AFib), closing the area of the heart known as the left atrial ...

Home March 29, 2017
Home
Ablation procedure, EP lab, Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation
Feature | Atrial Fibrillation

March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral anticoagulant ...

Home March 29, 2017
Home
Technology | Left Atrial Appendage (LAA) Occluders

March 22, 2017 — Aegis Medical Innovations Inc. announced that it has received Investigational Device Exemption approval ...

Home March 22, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

March 14, 2017 — More than 80 percent of stroke patients with a history of atrial fibrillation either received not ...

Home March 14, 2017
Home
Technology

February 16, 2017 — Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cr ...

Home February 16, 2017
Home
News | EP Lab

February 1, 2017 — Researchers have developed a technique that allows them to revive parts of human hearts in the ...

Home February 01, 2017
Home
News

January 25, 2017 — CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur ...

Home January 25, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

January 11, 2017 — For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of ...

Home January 11, 2017
Home
News | Left Atrial Appendage (LAA) Occluders

January 6, 2017 — SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial ...

Home January 06, 2017
Home
News | Atrial Fibrillation

January 4, 2017 — A smartphone application made it possible to use the iPhone camera to detect atrial fibrillation via ...

Home January 04, 2017
Home
Subscribe Now